Trevi Therapeutics (TRVI) Shares Issued (2018 - 2026)
Trevi Therapeutics (TRVI) posted quarterly Shares Issued of $12.0 million for Q1 2026, up 184.68% year-over-year from $4.2 million in Q1 2025, and up 29.46% quarter-over-quarter from $9.3 million in Q4 2025.
Trevi Therapeutics (TRVI) Shares Issued (2018 - 2026) Analysis & Trends
Trevi Therapeutics' Shares Issued history runs 9 years deep, the most recent figure standing at $12.0 million for Q1 2026.
- In Q1 2026, Shares Issued rose 184.68% year-over-year to $12.0 million; the TTM figure through Mar 2026 stood at $12.0 million (up 184.68% YoY), while the FY2025 annual figure was $9.3 million, up 18.58% from the prior year.
- Shares Issued for Q1 2026 stood at $12.0 million, up from $9.3 million in the prior quarter.
- The five-year high for Shares Issued was $12.0 million in Q1 2026, with the low at $2.0 million in Q2 2022.
- The 5-year median for Shares Issued is $5.1 million (2025), against an average of $5.6 million.
- The sharpest annual moves came in 2024 and 2025: Shares Issued surged 217.43% in 2024, then slumped 45.93% in 2025.
- Trevi Therapeutics' Shares Issued stood at $4.5 million in 2022, then climbed by 19.37% to $5.3 million in 2023, then soared by 47.66% to $7.8 million in 2024, then climbed by 18.58% to $9.3 million in 2025, then gained by 29.46% to $12.0 million in 2026.
- Business Quant data shows TRVI's Shares Issued at $12.0 million in Q1 2026, $9.3 million in Q4 2025, and $5.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Trevi Therapeutics | 2.63 Bn | 2.63 Bn | - | 11.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.78 Mn |
| Jun 30, 2026 | 11.78 Mn |
| Mar 31, 2026 | 12.04 Mn |
| Mar 31, 2026 | 12.04 Mn |
| Dec 31, 2025 | 9.30 Mn |
| Dec 31, 2025 | 9.30 Mn |
| Sep 30, 2025 | 5.02 Mn |
| Sep 30, 2025 | 5.02 Mn |
| Jun 30, 2025 | 5.11 Mn |
| Jun 30, 2025 | 5.11 Mn |
| Mar 31, 2025 | 4.23 Mn |
| Mar 31, 2025 | 4.23 Mn |
| Dec 31, 2024 | 7.84 Mn |
| Dec 31, 2024 | 7.84 Mn |
| Sep 30, 2024 | 3.58 Mn |
| Sep 30, 2024 | 3.58 Mn |
| Jun 30, 2024 | 7.96 Mn |
| Jun 30, 2024 | 7.96 Mn |
| Mar 31, 2024 | 7.82 Mn |
| Mar 31, 2024 | 7.82 Mn |